These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


412 related items for PubMed ID: 9310066

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Using antipsychotic agents in older patients.
    Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [Abstract] [Full Text] [Related]

  • 3. [Incidence of the deficit form in refractory schizophrenia].
    Samuelian JC.
    Encephale; 1996 Jun; 22 Spec No 2():19-23. PubMed ID: 8767037
    [Abstract] [Full Text] [Related]

  • 4. New drugs for the treatment of schizophrenia.
    Meltzer HY.
    Psychiatr Clin North Am; 1993 Jun; 16(2):365-85. PubMed ID: 8101373
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recent advances in the pharmacotherapy of schizophrenia.
    Borison RL.
    Harv Rev Psychiatry; 1997 Jun; 4(5):255-71. PubMed ID: 9385002
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
    Lerner V, Libov I, Kotler M, Strous RD.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology, etiology, diagnosis, and treatment of schizophrenia.
    Ryan PM.
    Am J Hosp Pharm; 1991 Jun; 48(6):1271-80. PubMed ID: 1677528
    [Abstract] [Full Text] [Related]

  • 16. [Clozapine--an atypical antipsychotic agents, its advantages and risks].
    Zvolský P, Hulínský J.
    Cesk Psychiatr; 1994 Dec; 90(6):328-40. PubMed ID: 7859323
    [Abstract] [Full Text] [Related]

  • 17. [Current data on neurologic sequelae caused by neuroleptics].
    Krebs MO.
    Encephale; 1995 Jun; 21 Spec No 3():49-52. PubMed ID: 7628342
    [Abstract] [Full Text] [Related]

  • 18. [Seroquel in a resistant schizophrenic with negative and positive symptoms].
    Reznik I, Benatov R, Sirota P.
    Harefuah; 1996 May 15; 130(10):675-7, 727. PubMed ID: 8794656
    [Abstract] [Full Text] [Related]

  • 19. Side effect profiles of new antipsychotic agents.
    Casey DE.
    J Clin Psychiatry; 1996 May 15; 57 Suppl 11():40-5; discussion 46-52. PubMed ID: 8941170
    [Abstract] [Full Text] [Related]

  • 20. The need for individualised antipsychotic drug therapy in patients with schizophrenia.
    Pani L.
    Eur Rev Med Pharmacol Sci; 2009 May 15; 13(6):453-9. PubMed ID: 20085126
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.